CVS 건강 공사
MX ˙ BMV ˙ US1266501006
SecurityMX:CVS / CVS Health Corporation
InstitutionKiltearn Partners LLP
Latest Disclosed Ownership365,068 shares
Latest Disclosed Value $ 26,219,184
Kiltearn Partners LLP reports 17.36% decrease in ownership of CVS / CVS Health Corporation

On May 14, 2026 - Kiltearn Partners LLP filed a 13F-HR form disclosing ownership of 365,068 shares of CVS Health Corporation (MX:CVS) valued at $26,219,184 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 13, 2026 disclosing 441,768 shares of CVS Health Corporation. This represents a change in shares of -17.36% during the quarter.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-14 2026-03-31 13F CVS HEALTH COM 126650100 365,068 -76,700 -17.36 26,219 -25.21 7.0545
2026-02-13 2025-12-31 13F CVS HEALTH COM 126650100 441,768 -88,400 -16.67 35,059 -12.29 7.5941
2025-11-13 2025-09-30 13F CVS HEALTH COM 126650100 530,168 8,500 1.63 39,969 11.07 8.0111
2025-08-13 2025-06-30 13F CVS HEALTH COM 126650100 521,668 -31,500 -5.69 35,985 -3.98 7.2356
2025-05-14 2025-03-31 13F CVS HEALTH COM 126650100 553,168 -95,200 -14.68 37,477 28.76 7.1423
2025-02-12 2024-12-31 13F CVS HEALTH COM 126650100 648,368 -68,500 -9.56 29,105 -35.43 4.8091
2024-11-13 2024-09-30 13F CVS HEALTH COM 126650100 716,868 -74,800 -9.45 45,077 -3.59 6.1274
2024-08-14 2024-06-30 13F CVS HEALTH COM 126650100 791,668 -69,500 -8.07 46,756 -31.76 5.6685
2024-05-15 2024-03-31 13F CVS HEALTH COM 126650100 861,168 -126,640 -12.82 68,515 -12.16 6.3324
2024-02-13 2023-12-31 13F CVS HEALTH COM 126650100 987,808 -20,660 -2.05 77,997 10.77 6.0026
2023-11-13 2023-09-30 13F CVS HEALTH COM 126650100 1,008,468 64,800 6.87 70,411 7.93 5.5614
2023-08-10 2023-06-30 13F CVS HEALTH COM 126650100 943,668 68,300 7.80 65,236 0.29 4.7689
2023-05-15 2023-03-31 13F CVS HEALTH COM 126650100 875,368 117,600 15.52 65,049 -7.88 4.6982
2023-02-09 2022-12-31 13F CVS HEALTH COM 126650100 757,768 -357,211 -32.04 70,616 -33.59 5.1828
2022-11-14 2022-09-30 13F CVS HEALTH COM 126650100 1,114,979 -44,630 -3.85 106,336 -1.04 6.1633
2022-08-09 2022-06-30 13F CVS HEALTH COM 126650100 1,159,609 -102,900 -8.15 107,449 -15.91 5.6265
2022-04-29 2022-03-31 13F CVS HEALTH COM 126650100 1,262,509 -235,900 -15.74 127,779 -17.34 5.4953
2022-02-10 2021-12-31 13F CVS HEALTH COM 126650100 1,498,409 -63,800 -4.08 154,576 16.60 6.3866
2021-11-09 2021-09-30 13F CVS HEALTH COM 126650100 1,562,209 -69,300 -4.25 132,569 -2.62 5.4799
2021-08-13 2021-06-30 13F CVS HEALTH COM 126650100 1,631,509 -15,400 -0.94 136,133 9.88 5.4540
2021-05-17 2021-03-31 13F CVS HEALTH COM 126650100 1,646,909 232,200 16.41 123,897 28.22 4.7319
2021-02-12 2020-12-31 13F CVS HEALTH COM 126650100 1,414,709 27,200 1.96 96,625 19.24 4.6247
2020-11-16 2020-09-30 13F CVS HEALTH COM 126650100 1,387,509 58,200 4.38 81,031 -6.18 4.9300
2020-08-13 2020-06-30 13F CVS HEALTH COM 126650100 1,329,309 -13,400 -1.00 86,365 8.41 4.8823
2020-05-14 2020-03-31 13F CVS HEALTH COM 126650100 1,342,709 -252,800 -15.84 79,663 -32.79 5.2932
2020-02-13 2019-12-31 13F CVS HEALTH COM 126650100 1,595,509 -74,700 -4.47 118,530 14.32 4.4779
2019-11-14 2019-09-30 13F CVS HEALTH COM 126650100 1,670,209 -130,500 -7.25 103,687 5.67 3.7661
2019-07-30 2019-06-30 13F CVS HEALTH COM 126650100 1,800,709 30,300 1.71 98,121 2.77 3.1091
2019-05-14 2019-03-31 13F CVS HEALTH COM 126650100 1,770,409 -217,008 -10.92 95,478 -26.68 2.7139
2019-02-08 2018-12-31 13F CVS HEALTH COM 126650100 1,987,417 -1,165,378 -36.96 130,216 -47.53 3.6607
2018-11-13 2018-09-30 13F CVS HEALTH COM 126650100 3,152,795 -43,600 -1.36 248,188 20.66 5.7184
2018-08-13 2018-06-30 13F CVS HEALTH COM 126650100 3,196,395 -75,900 -2.32 205,688 0.23 4.6285
2018-05-14 2018-03-31 13F CVS HEALTH COM 126650100 3,272,295 132,300 4.21 205,206 -9.86 4.9851
2018-02-13 2017-12-31 13F CVS HEALTH COM 126650100 3,139,995 1,074,795 52.04 227,650 35.55 5.6876
2017-11-13 2017-09-30 13F CVS HEALTH COM 126650100 2,065,200 1,461,400 242.03 167,942 245.69 4.9091
2017-08-10 2017-06-30 13F CVS HEALTH COM 126650100 603,800 603,800 48,582 1.5619
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.